Rilutek (Covis Pharma)


Welcome to the PulseAid listing for the Rilutek drug offered from Covis Pharma. This Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Covis Pharma
NON-PROPRIETARY NAME: riluzole
SUBSTANCE NAME: RILUZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-08-01
END MARKETING DATE: 0000-00-00


Rilutek HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRilutek from Covis Pharma
LABELER NAME: Covis Pharma
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2016-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70515-700_6ddc26d7-a6fe-46dd-8b49-c55aa111f83e
PRODUCT NDC: 70515-700
APPLICATION NUMBER: NDA020599

Other RILUZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingRILUZOLE
Apotex CorpRILUZOLE
Ascend Laboratories, LLCRiluzole
Covis PharmaRilutek
Covis Pharmaceuticals, Inc.Rilutek
Glenmark Pharmaceuticals Inc., USAriluzole
KAISER FOUNDATION HOSPITALSRilutek
Mylan Pharmaceuticals Inc.Riluzole
Rising Pharmaceuticals, Inc.Riluzole
sanofi-aventis U.S. LLCRilutek
Sun Pharmaceutical Industries LimitedRiluzole